{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:35:16Z","timestamp":1793532916733,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R24 EY032434"],"award-info":[{"award-number":["R24 EY032434"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02793-3","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:55:38Z","timestamp":1781002538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Engineered tRNA reduces vision loss in a mouse model of Leber congenital amaurosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Pawan K.","family":"Shahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enes","family":"Akyuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Gissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al Saneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjai K.","family":"Pillala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5854-0056","authenticated-orcid":false,"given":"Divya","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni M.","family":"Hanstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meha","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Fernandez Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Gamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-2744","authenticated-orcid":false,"given":"Christopher A.","family":"Ahern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5385-358X","authenticated-orcid":false,"given":"Bikash R.","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"2793_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrg775","volume":"3","author":"L Cartegni","year":"2002","unstructured":"Cartegni, L., Chew, S. L. & Krainer, A. R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285\u2013298 (2002).","journal-title":"Nat. Rev. Genet."},{"key":"2793_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/humu.20763","volume":"29","author":"M Mort","year":"2008","unstructured":"Mort, M., Ivanov, D., Cooper, D. N. & Chuzhanova, N. A. A meta-analysis of nonsense mutations causing human genetic disease. Hum. Mutat. 29, 1037\u20131047 (2008).","journal-title":"Hum. Mutat."},{"key":"2793_CR3","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/0883073810371129","volume":"25","author":"RS Finkel","year":"2010","unstructured":"Finkel, R. S. Read-through strategies for suppression of nonsense mutations in Duchenne\/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124). J. Child Neurol. 25, 1158\u20131164 (2010).","journal-title":"J. Child Neurol."},{"key":"2793_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","volume":"15","author":"KM Keeling","year":"2014","unstructured":"Keeling, K. M., Xue, X., Gunn, G. & Bedwell, D. M. Therapeutics based on stop codon readthrough. Annu Rev. Genomics Hum. Genet. 15, 371\u2013394 (2014).","journal-title":"Annu Rev. Genomics Hum. Genet."},{"key":"2793_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molmed.2023.01.004","volume":"29","author":"S Spelier","year":"2023","unstructured":"Spelier, S., van Doorn, E. P. M., van der Ent, C. K., Beekman, J. M. & Koppens, M. A. J. Readthrough compounds for nonsense mutations: bridging the translational gap. Trends Mol. Med. 29, 297\u2013314 (2023).","journal-title":"Trends Mol. Med."},{"key":"2793_CR6","doi-asserted-by":"crossref","unstructured":"Kantor, A., McClements, M. E. & MacLaren, R. E. CRISPR-Cas9 DNA base-editing and prime-editing. Int. J. Mol. Sci. 21, 6240 (2020).","DOI":"10.3390\/ijms21176240"},{"key":"2793_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.64.7.39","volume":"64","author":"S Drag","year":"2023","unstructured":"Drag, S., Dotiwala, F. & Upadhyay, A. K. Gene therapy for retinal degenerative diseases: progress, challenges, and future directions. Invest. Ophthalmol. Vis. Sci. 64, 39 (2023).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2793_CR8","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/IAE.0000000000002197","volume":"38","author":"GY Cho","year":"2018","unstructured":"Cho, G. Y., Schaefer, K. A., Bassuk, A. G., Tsang, S. H. & Mahajan, V. B. Crispr genome surgery in the retina in light of off-targeting. Retina 38, 1443\u20131455 (2018).","journal-title":"Retina"},{"key":"2793_CR9","doi-asserted-by":"publisher","first-page":"e1641","DOI":"10.1002\/wrna.1641","volume":"12","author":"JJ Porter","year":"2021","unstructured":"Porter, J. J., Heil, C. S. & Lueck, J. D. Therapeutic promise of engineered nonsense suppressor tRNAs. Wiley Interdiscip. Rev. RNA 12, e1641 (2021).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"2793_CR10","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1021\/acs.chemrev.4c00142","volume":"124","author":"C Ward","year":"2024","unstructured":"Ward, C. et al. Mechanisms and delivery of trna therapeutics. Chem. Rev. 124, 7976\u20138008 (2024).","journal-title":"Chem. Rev."},{"key":"2793_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41573-023-00829-9","volume":"23","author":"J Coller","year":"2024","unstructured":"Coller, J. & Ignatova, Z. tRNA therapeutics for genetic diseases. Nat. Rev. Drug Discov. 23, 108\u2013125 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2793_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature12302","volume":"500","author":"IS Fernandez","year":"2013","unstructured":"Fernandez, I. S. et al. Unusual base pairing during the decoding of a stop codon by the ribosome. Nature 500, 107\u2013110 (2013).","journal-title":"Nature"},{"key":"2793_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.omtn.2022.04.033","volume":"28","author":"W Ko","year":"2022","unstructured":"Ko, W., Porter, J. J., Sipple, M. T., Edwards, K. M. & Lueck, J. D. Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs. Mol. Ther. Nucleic Acids 28, 685\u2013701 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2793_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08329-4","volume":"10","author":"JD Lueck","year":"2019","unstructured":"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019).","journal-title":"Nat. Commun."},{"key":"2793_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82766-0","volume":"14","author":"S Pezzini","year":"2024","unstructured":"Pezzini, S. et al. Engineered tRNAs efficiently suppress CDKL5 premature termination codons. Sci. Rep. 14, 31791 (2024).","journal-title":"Sci. Rep."},{"key":"2793_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102032","volume":"34","author":"VG Blomquist","year":"2023","unstructured":"Blomquist, V. G. et al. Transfer RNA-mediated restoration of potassium current and electrical correction in premature termination long-QT syndrome hERG mutants. Mol. Ther. Nucleic Acids 34, 102032 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2793_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/hum.2010.067","volume":"22","author":"T Goldmann","year":"2011","unstructured":"Goldmann, T., Overlack, N., Wolfrum, U. & Nagel-Wolfrum, K. PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C. Hum. Gene Ther. 22, 537\u2013547 (2011).","journal-title":"Hum. Gene Ther."},{"key":"2793_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jcf.2015.07.007","volume":"15","author":"DD Zomer-van Ommen","year":"2016","unstructured":"Zomer-van Ommen, D. D. et al. Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids. J. Cyst. Fibros. 15, 158\u2013162 (2016).","journal-title":"J. Cyst. Fibros."},{"key":"2793_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-020-00369-5","volume":"15","author":"J Frew","year":"2020","unstructured":"Frew, J. et al. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency. Mol. Neurodegener. 15, 21 (2020).","journal-title":"Mol. Neurodegener."},{"key":"2793_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04533-3","volume":"604","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice. Nature 604, 343\u2013348 (2022).","journal-title":"Nature"},{"key":"2793_CR21","doi-asserted-by":"publisher","first-page":"e00391","DOI":"10.1016\/j.neurot.2024.e00391","volume":"21","author":"J Wang","year":"2024","unstructured":"Wang, J., Gao, G. & Wang, D. Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders. Neurotherapeutics 21, e00391 (2024).","journal-title":"Neurotherapeutics"},{"key":"2793_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4161\/19336950.2014.959809","volume":"8","author":"M Kumar","year":"2014","unstructured":"Kumar, M. & Pattnaik, B. R. Focus on Kir7.1: physiology and channelopathy. Channels 8, 488\u2013495 (2014).","journal-title":"Channels"},{"key":"2793_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/humu.22807","volume":"36","author":"BR Pattnaik","year":"2015","unstructured":"Pattnaik, B. R. et al. A novel KCNJ13 nonsense mutation and loss of Kir7.1 channel function causes Leber congenital amaurosis (LCA16). Hum. Mutat. 36, 720\u2013727 (2015).","journal-title":"Hum. Mutat."},{"key":"2793_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2157339","volume":"12","author":"TY Wang","year":"2023","unstructured":"Wang, T. Y. et al. A novel viral vaccine platform based on engineered transfer RNA. Emerg. Microbes Infect. 12, 2157339 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"2793_CR25","doi-asserted-by":"publisher","first-page":"7056","DOI":"10.1093\/emboj\/18.24.7056","volume":"18","author":"JD Alfonzo","year":"1999","unstructured":"Alfonzo, J. D., Blanc, V., Estevez, A. M., Rubio, M. A. & Simpson, L. C to U editing of the anticodon of imported mitochondrial tRNA(Trp) allows decoding of the UGA stop codon in Leishmania tarentolae. EMBO J. 18, 7056\u20137062 (1999).","journal-title":"EMBO J."},{"key":"2793_CR26","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Nishikawaji, Y., Kawakami, H. & Kosai, K. I. Adenovirus biology, recombinant adenovirus, and adenovirus usage in gene therapy. Viruses 13, 2502 (2021).","DOI":"10.3390\/v13122502"},{"key":"2793_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s11262-017-1471-x","volume":"53","author":"N Brunetti-Pierri","year":"2017","unstructured":"Brunetti-Pierri, N. & Ng, P. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models. Virus Genes 53, 684\u2013691 (2017).","journal-title":"Virus Genes"},{"key":"2793_CR28","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/v2091886","volume":"2","author":"F Vetrini","year":"2010","unstructured":"Vetrini, F. & Ng, P. Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives. Viruses 2, 1886\u20131917 (2010).","journal-title":"Viruses"},{"key":"2793_CR29","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S1470-2045(23)00347-9","volume":"24","author":"Y Umemura","year":"2023","unstructured":"Umemura, Y. et al. Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial. Lancet Oncol. 24, 1042\u20131052 (2023).","journal-title":"Lancet Oncol."},{"key":"2793_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1101\/pdb.prot5627","volume":"2011","author":"DJ Palmer","year":"2011","unstructured":"Palmer, D. J. & Ng, P. Rescue, amplification, and large-scale production of helper-dependent adenoviral vectors. Cold Spring Harb. Protoc. 2011, 857\u2013866 (2011).","journal-title":"Cold Spring Harb. Protoc."},{"key":"2793_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-4939-6352-2_5","volume":"1474","author":"MS Montesinos","year":"2016","unstructured":"Montesinos, M. S., Satterfield, R. & Young, S. M. Jr Helper-dependent adenoviral vectors and their use for neuroscience applications. Methods Mol. Biol. 1474, 73\u201390 (2016).","journal-title":"Methods Mol. Biol."},{"key":"2793_CR32","doi-asserted-by":"crossref","unstructured":"Kabra, M. et al. Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy. J. Clin. Invest. 133, e171356 (2023).","DOI":"10.1172\/JCI171356"},{"key":"2793_CR33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41586-023-06133-1","volume":"618","author":"S Albers","year":"2023","unstructured":"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842\u2013848 (2023).","journal-title":"Nature"},{"key":"2793_CR34","doi-asserted-by":"publisher","first-page":"14112","DOI":"10.1093\/nar\/gkae1112","volume":"52","author":"JJ Porter","year":"2024","unstructured":"Porter, J. J., Ko, W., Sorensen, E. G. & Lueck, J. D. Optimization of ACE-tRNAs function in translation for suppression of nonsense mutations. Nucleic Acids Res. 52, 14112\u201314132 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2793_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1126\/science.271.5246.163","volume":"271","author":"DA Dougherty","year":"1996","unstructured":"Dougherty, D. A. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 271, 163\u2013168 (1996).","journal-title":"Science"},{"key":"2793_CR36","doi-asserted-by":"publisher","first-page":"14713","DOI":"10.1021\/bi980809c","volume":"37","author":"WM Yau","year":"1998","unstructured":"Yau, W. M., Wimley, W. C., Gawrisch, K. & White, S. H. The preference of tryptophan for membrane interfaces. Biochemistry 37, 14713\u201314718 (1998).","journal-title":"Biochemistry"},{"key":"2793_CR37","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","volume":"96","author":"N Morral","year":"1999","unstructured":"Morral, N. et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA 96, 12816\u201312821 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2793_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41434-019-0061-z","volume":"26","author":"E Leggiero","year":"2019","unstructured":"Leggiero, E. et al. Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor\/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice. Gene Ther. 26, 121\u2013130 (2019).","journal-title":"Gene Ther."},{"key":"2793_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1089\/hum.2010.175","volume":"22","author":"L Du","year":"2011","unstructured":"Du, L., Dronadula, N., Tanaka, S. & Dichek, D. A. Helper-dependent adenoviral vector achieves prolonged, stable expression of interleukin-10 in rabbit carotid arteries but does not limit early atherogenesis. Hum. Gene Ther. 22, 959\u2013968 (2011).","journal-title":"Hum. Gene Ther."},{"key":"2793_CR40","doi-asserted-by":"publisher","first-page":"e10258","DOI":"10.1002\/btm2.10258","volume":"7","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z., Anselmo, A. C. & Mitragotri, S. Viral vector-based gene therapies in the clinic. Bioeng. Transl. Med. 7, e10258 (2022).","journal-title":"Bioeng. Transl. Med."},{"key":"2793_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/mt.2008.257","volume":"17","author":"N Brunetti-Pierri","year":"2009","unstructured":"Brunetti-Pierri, N. et al. Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates. Mol. Ther. 17, 327\u2013333 (2009).","journal-title":"Mol. Ther."},{"key":"2793_CR42","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nm867","volume":"9","author":"H Kojima","year":"2003","unstructured":"Kojima, H. et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med. 9, 596\u2013603 (2003).","journal-title":"Nat. Med."},{"key":"2793_CR43","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1182\/blood-2003-05-1426","volume":"103","author":"BD Brown","year":"2004","unstructured":"Brown, B. D. et al. Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A. Blood 103, 804\u2013810 (2004).","journal-title":"Blood"},{"key":"2793_CR44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/gt.2015.45","volume":"22","author":"J Poutou","year":"2015","unstructured":"Poutou, J. et al. Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model. Gene Ther. 22, 696\u2013706 (2015).","journal-title":"Gene Ther."},{"key":"2793_CR45","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/s41588-024-01878-5","volume":"56","author":"I Toledano","year":"2024","unstructured":"Toledano, I., Supek, F. & Lehner, B. Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules. Nat. Genet. 56, 1914\u20131924 (2024).","journal-title":"Nat. Genet."},{"key":"2793_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/iub.70031","volume":"77","author":"E Vitale","year":"2025","unstructured":"Vitale, E. et al. Nonsense mutations in rare and ultra-rare human disorders: an overview. IUBMB Life 77, e70031 (2025).","journal-title":"IUBMB Life"},{"key":"2793_CR47","doi-asserted-by":"crossref","unstructured":"Morais, P., Adachi, H. & Yu, Y. T. Suppression of nonsense mutations by new emerging technologies. Int. J. Mol. Sci. 21, 45 (2020).","DOI":"10.3390\/ijms21124394"},{"key":"2793_CR48","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1089\/hum.2019.159","volume":"30","author":"IC Han","year":"2019","unstructured":"Han, I. C. et al. Helper-dependent adenovirus transduces the human and rat retina but elicits an inflammatory reaction when delivered subretinally in rats. Hum. Gene Ther. 30, 1371\u20131384 (2019).","journal-title":"Hum. Gene Ther."},{"key":"2793_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/A:1014238221426","volume":"36","author":"AV Kiselev","year":"2002","unstructured":"Kiselev, A. V. et al. Suppression of nonsense mutations in the Dystrophin gene by a suppressor tRNA gene. Mol. Biol. 36, 43\u201347 (2002).","journal-title":"Mol. Biol."},{"key":"2793_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66176-y","volume":"16","author":"C Ren","year":"2025","unstructured":"Ren, C. et al. AAV-delivered engineered suppressor tRNA rescues visual function in mice with an inherited retinal disease. Nat. Commun. 16, 11185 (2025).","journal-title":"Nat. Commun."},{"key":"2793_CR51","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ajhg.2018.12.019","volume":"104","author":"PK Shahi","year":"2019","unstructured":"Shahi, P. K. et al. Gene augmentation and readthrough rescue channelopathy in an ipsc-rpe model of congenital blindness. Am. J. Hum. Genet. 104, 310\u2013318 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"2793_CR52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.stemcr.2017.12.004","volume":"10","author":"B Steyer","year":"2018","unstructured":"Steyer, B. et al. Scarless genome editing of human pluripotent stem cells via transient puromycin selection. Stem Cell Rep. 10, 642\u2013654 (2018).","journal-title":"Stem Cell Rep."},{"key":"2793_CR53","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajhg.2020.06.011","volume":"107","author":"D Sinha","year":"2020","unstructured":"Sinha, D. et al. Human iPSC modeling reveals mutation-specific responses to gene therapy in a genotypically diverse dominant maculopathy. Am. J. Hum. Genet. 107, 278\u2013292 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"2793_CR54","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.xpro.2022.101582","volume":"3","author":"R Sharma","year":"2022","unstructured":"Sharma, R., Bose, D., Montford, J., Ortolan, D. & Bharti, K. Triphasic developmentally guided protocol to generate retinal pigment epithelium from induced pluripotent stem cells. STAR Protoc. 3, 101582 (2022).","journal-title":"STAR Protoc."},{"key":"2793_CR55","doi-asserted-by":"crossref","unstructured":"Lubbert, M. et al. A novel region in the Ca(V)2.1 alpha(1) subunit C-terminus regulates fast synaptic vesicle fusion and vesicle docking at the mammalian presynaptic active zone. Elife 6, e28412 (2017).","DOI":"10.7554\/eLife.28412"},{"key":"2793_CR56","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1152\/jn.00713.2011","volume":"106","author":"MS Montesinos","year":"2011","unstructured":"Montesinos, M. S., Chen, Z. X. & Young, S. M. pUNISHER: a high-level expression cassette for use with recombinant viral vectors for rapid and long term in vivo neuronal expression in the CNS. J. Neurophysiol. 106, 3230\u20133244 (2011).","journal-title":"J. Neurophysiol."},{"key":"2793_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hum.2005.16.1","volume":"16","author":"DJ Palmer","year":"2005","unstructured":"Palmer, D. J. & Ng, P. Helper-dependent adenoviral vectors for gene therapy. Hum. Gene Ther. 16, 1\u201316 (2005).","journal-title":"Hum. Gene Ther."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02793-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02793-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02793-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:07:54Z","timestamp":1781006874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02793-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2793"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02793-3","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.R.P. is a scientific co-founder and board member of Hubble Therapeutics. D.M.G. is the co-founder and chief scientific officer of Opsis Therapeutics and a consultant for Fujifilm Cellular Dynamics, Inc., and BlueRock Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"225"}}